Kamada KMDA
NASDAQ KMDA
$8.69 +0.07 (+0.87%)
At close: Sep 29, 2026 · 4:00 PM EDT

Kamada (KMDA) Non-Current Assets (2012 - 2026)

Updated

Kamada's Non-Current Assets was $183.59 million in the quarter ended Jun 30, 2026, down 0.7% from $184.9 million a year earlier and down 0.1% from the prior quarter.

Analysis

Kamada (KMDA) Non-Current Assets (2012 - 2026) Analysis & Trends

As of Dec 31, 2025, Non-Current Assets at Kamada came in at $185.64 million, down 1.2% from the prior year.

  • Non-Current Assets shows a five-year compound annual growth rate of 41.5% (years ended Dec 2020 to Dec 2025).
  • In earlier years, Non-Current Assets was $187.91 million in the year ended Dec 31, 2024 (+1.6%), $184.95 million in the year ended Dec 31, 2023 (+0.9%), $183.37 million in the year ended Dec 31, 2022 (-2.8%) and $188.62 million in the year ended Dec 31, 2021 (+475.9%).
  • The figure for the quarter ended Jun 30, 2026 marks the lowest quarterly Non-Current Assets since the quarter ended Dec 31, 2022.
  • Compared with a year earlier, Non-Current Assets has declined for four straight quarters, with an average decline of 0.1% over the last eight quarters.
  • The best year-over-year quarter for Non-Current Assets over five years was the quarter ended Dec 31, 2021 (growth of 475.9%); the worst was the quarter ended Dec 31, 2022 (a decline of 2.8%).
  • Per Business Quant data, KMDA's Non-Current Assets in the three quarters before the quarter ended Jun 30, 2026 was $183.79 million (quarter ended Mar 31, 2026), $185.64 million (quarter ended Dec 31, 2025) and $184.48 million (quarter ended Sep 30, 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Assets (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 141.29 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn 101.45 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn 125.00 Mn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn 94.68 Bn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn 87.87 Bn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 60.68 Bn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn 35.42 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 159.77 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn 14.88 Bn
10 Kamada 497.25 Mn 206.31 Mn 22.47 Mn 183.59 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 183.59 Mn
Mar 31, 2026 183.79 Mn
Dec 31, 2025 185.64 Mn
Sep 30, 2025 184.48 Mn
Jun 30, 2025 184.90 Mn
Mar 31, 2025 186.61 Mn
Dec 31, 2024 187.91 Mn
Sep 30, 2024 186.80 Mn
Jun 30, 2024 184.61 Mn
Mar 31, 2024 185.37 Mn
Dec 31, 2023 184.95 Mn
Sep 30, 2023 183.90 Mn
Jun 30, 2023 184.71 Mn
Mar 31, 2023 185.39 Mn
Dec 31, 2022 183.37 Mn
Sep 30, 2022 184.48 Mn
Jun 30, 2022 185.53 Mn
Mar 31, 2022 186.93 Mn
Dec 31, 2021 188.62 Mn
Sep 30, 2021 37.58 Mn
API Access

Kamada Non-Current Assets API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-current-assets&ticker=KMDA&period=max&api_key=YOUR_API_KEY